VINCRISTIN
Showing 1 - 25 of 39
Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)
Recruiting
- Acute Lymphoid Leukemia
- +3 more
- Prednisone
- +9 more
-
São Paulo, SP, BrazilInstituto do Cancer do Estado de Sao Paulo
Jul 24, 2023
Sarcoma, Ewing Trial in China (TK216+Vincristin)
Not yet recruiting
- Sarcoma, Ewing
- TK216+Vincristin
-
Beijing, Beijing, China
- +7 more
Jul 25, 2022
Posttransplant Lymphoproliferative Disorder Trial in Germany (Rituximab sc, Rituximab sc consolidation, Rituximab sc combined
Completed
- Posttransplant Lymphoproliferative Disorder
- Rituximab sc
- +3 more
-
Aachen, Germany
- +17 more
Aug 22, 2022
Lymphoma, Large B-Cell, Diffuse, CNS Tumors, Primary Trial in France (Lenalidomide, Ibrutinib)
Recruiting
- Lymphoma, Large B-Cell, Diffuse
- Central Nervous System Neoplasms, Primary
-
Amiens, France
- +26 more
Nov 30, 2022
Medulloblastoma Trial in Germany (maintenance chemo (vincristin, cisplatin and CCNU), Radiotherapy)
Completed
- Medulloblastoma
- maintenance chemotherapy (vincristin, cisplatin and CCNU)
- Radiotherapy
-
Berlin, Germany
- +14 more
Mar 27, 2020
Retinoblastoma, Children, Retinal Tumor Trial in Paris (drug, device, radiation)
Recruiting
- Retinoblastoma
- +2 more
- VP16, carboplatin
- +7 more
-
Paris, FranceInstitut Curie
Aug 6, 2020
Hodgkin Lymphoma Trial in France (brentuximab vedotin, Cyclophosphamide, Adriamycin)
Completed
- Hodgkin Lymphoma
- brentuximab vedotin
- +9 more
-
Argenteuil, France
- +29 more
Jul 23, 2021
Sarcoma, Neuroblastoma, Wilms Tumor Trial run by the (Marqibo)
Completed
- Sarcoma
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 14, 2020
CNS Lymphoma Trial in Aarhus (Immunochemo)
Completed
- Central Nervous System Lymphoma
-
Aarhus, DenmarkElisa Jacobsen Pulczynski
Aug 3, 2022
Lymphoma, Peripheral Neuropathy Trial in Orléans (Clinical scales of CIPN)
Recruiting
- Lymphoma
- Peripheral Neuropathy
- Clinical scales of CIPN
-
Orléans, FranceCHR Orléans
May 12, 2022
Mantle Cell Lymphoma Trial in United States (R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.)
Active, not recruiting
- Mantle Cell Lymphoma
- R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.
-
Basking Ridge, New Jersey
- +4 more
Dec 1, 2022
Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)
Recruiting
- Diffuse Large Cell Lymphoma
- +4 more
- Vincristine
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Ewing's Sarcoma Trial in Italy (Standard treatment (as per protocol ISG SSG III), Intensified chemo)
Active, not recruiting
- Ewing's Sarcoma
- Standard treatment (as per protocol ISG SSG III)
- Intensified chemotherapy
-
Aviano, Pordenone, Italy
- +13 more
Oct 29, 2021
Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T Cell Lymphoma, ALK-negative Anaplastic Large Cell
Unknown status
- Peripheral T-Cell Lymphoma, Not Otherwise Specified
- +5 more
- CEOP/IVE/GDP chemotherapy regimen
- CEOP chemotherapy regimen for 6 cycles
-
Fuzhou, Fujian, China
- +3 more
Mar 7, 2020
Lymphoma Trial in Germany, Switzerland (biological, drug, radiation)
Completed
- Lymphoma
- filgrastim
- +7 more
-
Aachen, Germany
- +174 more
May 14, 2021
Retinoblastoma Trial in France (other, drug, radiation, procedure)
Recruiting
- Retinoblastoma
- Observation
- +8 more
-
Saint-Denis, La Réunion, France
- +26 more
Aug 6, 2020
Childhood Renal Tumor Trial (treatment Vincristin, treatment Actinomycin-D, treatment Doxorubicin)
Not yet recruiting
- Childhood Renal Tumor
- treatment Vincristin
- +4 more
- (no location specified)
Sep 12, 2018
Constipation, Childhood Acute Lymphoblastic Leukemia, Neurofibromatosis 1 Trial in Aarhus (3D-Transit)
Recruiting
- Constipation
- +3 more
- 3D-Transit
-
Aarhus, DenmarkAarhus University Hospital
Nov 23, 2020
Lymphoma, T-Cell, Peripheral Trial in Worldwide (CHOP14 chemo (cyclophosphamide, hydroxydaunorubicin, vincristin, prednison)
Completed
- Lymphoma, T-Cell, Peripheral
- CHOP14 chemotherapy (cyclophosphamide, hydroxydaunorubicin, vincristin, prednison) plus G-CSF, combined with alemtuzumab
- CHOP14 chemotherapy (see specification under Arm B) plus G-CSF
-
Linz, Austria
- +58 more
Feb 27, 2019
Lymphoma, Hodgkin Disease, Lymphoma, Hodgkin Disease Trial in Stanford, Vallejo (Vincristine, Cyclophosphamide, Doxorubicin)
Completed
- Lymphoma, Hodgkin Disease
- +3 more
- Vincristine
- +6 more
-
Stanford, California
- +1 more
Jun 25, 2018
ALK-negative Anaplastic Large Cell Lymphoma, Peripherial T Cell Lymphoma,Not Otherwise Specified, Angioimmunoblastic T Cell
Unknown status
- ALK-negative Anaplastic Large Cell Lymphoma
- +5 more
- Cyclophosphamide 750mg/m2
- +8 more
-
Shanghai, Shanghai, ChinaRuijin hospital
Nov 10, 2017
Leukemia, Precursor-B Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Houston (Cytarabine, Daunorubicin,
Terminated
- Leukemia
- +3 more
- Cytarabine
- +12 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 9, 2018
Acute Lymphoblastic Leukemia Trial in Worldwide (PEG Asparaginase at six weeks interval, PEG Asparaginase at two weeks interval)
Completed
- Acute Lymphoblastic Leukemia
- PEG Asparaginase at six weeks interval
- PEG Asparaginase at two weeks interval
-
Copenhagen, Denmark
- +5 more
Apr 20, 2017
Multiple Myeloma Trial in Shanghai (Single ASCT with Thalidomide maintenance)
Suspended
- Multiple Myeloma
- Single ASCT with Thalidomide maintenance
-
Shanghai, ChinaRui Jin Hospital, Shanghai JiaoTong University School of Medicin
May 9, 2016